Skip to main content

Series B Biotechnology Companies

Explore 427 biotechnology startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
427
Total Funding
$1.3B
Avg Funding
$52.1M
Cities
21

Export 427 Series B Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Cambridge, United States
$77.0M
raised

Crossbow Therapeutics is a biotech company that develops targeted therapies to address cancer antigens.

Mar 2026
Series B

Founder Contacts

41,000+ verified contacts

Thousand Oaks, United States
$150.0M
raised

Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain.

Mar 2025
Series B

Founder Contacts

41,000+ verified contacts

Bothell, United States
$110.0M
raised

Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.

Mar 2025
Series B

Founder Contacts

41,000+ verified contacts

Santa Cruz, United States
$45.0M
raised

Unnatural Products is a biotech company that focuses on unlocking macrocyclic peptides to create drug therapies.

Mar 2026
Series B

Founder Contacts

41,000+ verified contacts

Torino, Italy
$20.4M
raised

Kither Biotech is a pharmaceutical product company that developmens of new drugs to treat chronic inflammatory diseases

Mar 2022
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 427 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Brussels, Belgium
$88.2M
raised

Precirix is a platform that is developing radio-immunotherapeutic drugs for cancer patients.

Mar 2022
Series B

Founder Contacts

41,000+ verified contacts

Boston, United States
$50.0M
raised

Mori is a developer of a protective silk coating product that extends the shelf life of perishable foods.

Mar 2022
Series B

Founder Contacts

41,000+ verified contacts

Princeton, United States
$85.0M
raised

QuantX Biosciences is a biotechnology company that specializes in computational drug discovery and small-molecule therapeutic products.

Feb 2026
Series B

Founder Contacts

41,000+ verified contacts

Illkirch, France
$23.5M
raised

Kainova Therapeutics develops small molecules targeting G-coupled protein receptors.

Feb 2026
Series B

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$30.0M
raised

Prokarium is biopharmaceutical company leading the oncology field of microbial immunotherapy.

Feb 2023
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 427 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
New York, United States

Intrommune Therapeutics is a New York-based biotechnology company.

Feb 2022
Series B

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$40.0M
raised

IgGenix is a biotechnology company.

Feb 2023
Series B

Founder Contacts

41,000+ verified contacts

Ann Arbor, United States
$1.5M
raised

ecovia I bio offers high-performing biobased ingredients and materials from sustainable processes.

Feb 2026
Series B

Founder Contacts

41,000+ verified contacts

Niigata, Japan
$3.2M
raised

UniBio is a biotech company that aims to produce useful proteins in plant cells via synthesis and the transient gene expression method.

Feb 2024
Series B

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$135.0M
raised

Chroma Medicine is a biotechnology company that develops genetic medicines for the treatment of genetic disorders.

Feb 2023
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 427 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
New York, United States

Woolsey Pharmaceuticals specializes in reinventing ways to treat some of the world’s most challenging diseases.

Feb 2025
Series B

Founder Contacts

41,000+ verified contacts

Seattle, United States

Cyrus Biotechnology is a developer of Rosetta software platform that solves drug discovery problems.

Feb 2024
Series B

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$60.0M
raised

BreezeBio is a biotechnology business that creates genetic therapies using precision, non-viral delivery across clinically important tissues

Feb 2026
Series B

Founder Contacts

41,000+ verified contacts

Budapest, Hungary
$25.0M
raised

Turbine's platform understands the inner mechanisms of cancer enabling the discovery of novel targets & precision medicinal therapies.

Feb 2026
Series B

Founder Contacts

41,000+ verified contacts

Burlingame, United States
$10.5M
raised

Trace Genomics provides genetic insights into soil, helping farmers optimize their agricultural practices for better crop yield.

Feb 2024
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 427 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
College Park, United States
$75.0M
raised

Altesa is a clinical-stage biopharmaceutical company dedicated to accelerating the development of new treatments

Feb 2026
Series B

Founder Contacts

41,000+ verified contacts

San Diego, United States
$7.0M
raised

Cellics is committed to saving lives and improving patients’ health using innovative biomimetic nanomedicines.

Feb 2022
Series B

Founder Contacts

41,000+ verified contacts

Boston, United States
$193.0M
raised

Aera Therapeutics is a biotechnology firm that employs its own protein nanoparticle (PNP) delivery platform.

Feb 2023
Series B

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$42.5M
raised

NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.

Feb 2024
Series B

Founder Contacts

41,000+ verified contacts

Carmel, United States
$30.0M
raised

Sudo Biosciences is a biopharma company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain.

Feb 2024
Series B

Founder Contacts

41,000+ verified contacts

Showing 151 to 175 of 427 companies

Ready to Connect with Series B Biotechnology Startups?

Get verified founder emails, funding details, and company data for 427 series b biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked